文献速递泌尿系感染

改良经肛门括约肌路径(York Mason)修复非放疗性直肠尿道瘘:患者报告的粪便控便结局

Modified Transanosphincteric (York Mason) Repair of Nonradiated Rectourinary Fistulae: Patient-reported Fecal Continence Outcomes.
PubMed 文献 · Urology · 2018-05-16

本研究回顾性分析了2008至2016年单中心17例接受改良York Mason(MYM)联合臀肌游离脂肪移植修复非放疗性直肠尿道瘘(RUF)的患者,中位随访39.4个月,16例(94%)实现初次闭合成功。电话调查的10例患者中位PGI-I评分为2(「明显好转」),平均改善89.5%,平均CCFFIS评分为1.4(范围0-5),对粪便控便影响轻微。

要点

  • MYM修复非放疗性RUF初次闭合成功率达94%(16/17)。
  • 患者报告粪便控便影响轻微,平均CCFFIS仅1.4(0-20分制)。
  • 中位PGI-I评分2,患者总体印象为「明显好转」。

核心结论

  • MYM技术治疗非放疗性直肠尿道瘘成功率高,对粪便控便影响可忽略。

研究设计与样本

  • 单中心回顾性研究,纳入2008至2016年接受MYM联合臀肌游离脂肪移植修复非放疗性RUF的17例患者。
  • 通过电话施测CCFFIS和PGI-I问卷评估粪便控便结局。

主要发现

  • 17例患者平均年龄61.8岁,最常见病因为前列腺切除术11例(65%)、冷冻消融2例(12%)、经肛门肿瘤切除2例(12%)。
  • 3例(18%)既往经会阴修复失败,平均瘘管大小10.1 mm(范围2-25),中位手术时间231分钟(范围151-365),中位住院时间2.0天(范围1-13)。
  • 中位随访39.4个月,16/17例(94%)初次闭合成功。
  • 10例电话应答者中位PGI-I评分2(「明显好转」),平均改善89.5%,平均CCFFIS 1.4(范围0-5,0为完全控便,20为完全失禁)。
  • 2例(20%)报告罕见(<1次/月)粪便失禁,2/10例(20%)报告频繁排气失禁,但无人报告显著生活方式改变或寻求进一步肠道症状治疗。

临床怎么用

  • 对于非放疗性直肠尿道瘘,MYM联合臀肌游离脂肪移植可作为高成功率且对控便功能影响小的修复选择。

局限性

  • 单中心回顾性设计,样本量小(17例),仅10例完成电话问卷,随访依赖患者报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To review our experience with the modified York Mason (MYM) procedure in the treatment of rectourinary fistulas (RUFs) and to assess fecal continence using patient-reported measures. MATERIALS AND METHODS: A retrospective review was performed of patients who underwent MYM repair of nonradiated RUF with gluteal free fat graft from 2008 to 2016 at a single institution. Success was defined as resolution of the fistula without need for further surgery. The Cleveland Clinic-Florida Wexner Fecal Incontinence Score (CCFFIS) and the Patient Global Impression of Improvement (PGI-I) surveys were administered by phone. RESULTS: Of 17 patients who underwent MYM repair with a mean age of 61.8 years old, the most common fistula etiologies were prostatectomy in 11 patients (65%), cryoablation in 2 patients (12%), and transanal tumor excision (12%). Three patients (18%) failed prior perineal repairs. The mean fistula size was 10.1 mm (range 2-25), the median operative time was 231 minutes (range 151-365), and the median length of stay was 2.0 days (range 1-13). At the median follow-up of 39.4 months, 16 of the 17 patients (94%) had successful primary closures. The condition of the 10 patients who responded to the phone survey was "much better" (median PGI-I score 2), with 89.5% mean improvement. The mean CCFFIS was 1.4 (range 0-5) on a scale of 0 (total continence) to 20 (complete incontinence). Two patients (20%) reported rare (<1 per month) fecal incontinence, and 2/10 (20%) reported frequent flatal incontinence, but none reported significant lifestyle change or sought further treatment for bowel symptoms. CONCLUSION: The MYM technique has a high success rate in the treatment of nonradiated RUF with negligible impact on fecal continence.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. McKibben MJ, Fuchs JS, Rozanski AT, et al. Modified Transanosphincteric (York Mason) Repair of Nonradiated Rectourinary Fistulae: Patient-reported Fecal Continence Outcomes. Urology. 2018. PMID: 29777788. doi:10.1016/j.urology.2018.05.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。